« Back
Home /
Sitagliptin

Sitagliptin

Item no.	TMO-T0242-1ml
Manufacturer	TargetMol
Amount	1ml/10mM (In DMSO)
Category	Metabolism Diabetes Regulation of Appetite
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Similar products	486460-32-6
Available
Description	Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin.
Shipping temperature	Cool Pack
Storage Temperature	-20° C
Target name	DPP-4 inhibitor
CAS	486460-32-6
Purity	0, 98
Formulate	C16H15F6N5O
Smeles	NC(CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F) CC1=CC(F)=C(F)C=C1F
Key words	Sitagliptin, MK-431; MK431; MK 431

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0242-1ml-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1ml/10mM (In DMSO)

not available